Should I Buy LABFF Stock in 2026?
Data-driven analysis and honest assessment for Laboratorios Farmaceuticos Rovi, S.A./Adr
Current Price: $90.61P/E: 28.9
Decision Score
Weak
Based on 6 fundamental factors
Score Breakdown:
Elevated P/E of 28.9
Slow growth of 0%
Thin margins (0% net)
Financial health data limited
Low FCF yield of 3.0%
No recent insider activity
Key Investment Metrics
Current Price
$90.61
P/E Ratio
28.95
Revenue Growth
0.1%
Profit Margin
0.2%
Market Cap
$4.6B
Dividend Yield
None
How LABFF Compares to Competitors
Understanding how LABFF stacks up against peers helps inform your investment decision.
How LABFF Compares to Peers
Upcoming Events for LABFF
+5 Reasons TO Buy LABFF
1. High gross margins of 63%
moderateGross margins above 50% typically indicate strong brand value or intellectual property moats.
-5 Reasons NOT to Buy LABFF
1. Thin profit margins of 0.2%
high riskLow margins provide little cushion against cost increases or pricing pressure.
2. Minimal revenue growth
low riskGrowth of 0.1% barely keeps pace with inflation.
Who Should Buy LABFF?
Investment Profile
Risk Level
High
Recommended Holding Period
3-5 years
Best For:
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in LABFF, compare these Healthcare peers:
Pro tip: Compare LABFF directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for LABFF
Frequently Asked Questions
What is LABFF stock price today?
LABFF (Laboratorios Farmaceuticos Rovi, S.A./Adr) stock is trading at $90.61 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is LABFF stock going up or down today?
LABFF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy LABFF stock now?
The decision to buy LABFF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is LABFF a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for LABFF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is LABFF stock overvalued or undervalued?
LABFF currently trades at a P/E ratio of 28.95, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if LABFF is fairly priced.
What is LABFF's P/E ratio?
LABFF has a price-to-earnings (P/E) ratio of 28.95, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is LABFF's market cap?
LABFF (Laboratorios Farmaceuticos Rovi, S.A./Adr) has a market capitalization of $4.63 billion, making it a small-cap stock.
What is LABFF's price to book ratio?
LABFF trades at a price-to-book (P/B) ratio of 8.75, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Laboratorios Farmaceuticos Rovi, S.A./Adr
Full Stock Analysis
Complete LABFF overview with charts and data
Is LABFF Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how LABFF stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Laboratorios Farmaceuticos Rovi, S.A./Adr
Complete LABFF Analysis
Compare LABFF With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.